Portolan Capital Management LLC recently announced the acquisition of new stake in Eros International Plc (NYSE:EROS). This fresh investment now brings its stake to 1.35% valued currently at $5.96 million. In addition, SSgA Funds Management, Inc. raised its holdings by 0.27 million to 1.28 million shares. And Arrowstreet Capital LP has lifted its position by 95.39% or 0.61 million shares – to 1.25 million shares.
With over 3.54 million Eros International Plc (EROS) shares trading Monday and a closing price of $3.11 on the day, the dollar volume was approximately $11.0 million. The shares have shown a positive weekly performance of 14.76% and its price on 08/31/20 lost nearly -1.58%. Currently, there are 155.58M common shares owned by the public and among those 132.81M shares have been available to trade.
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 1 analysts who have offered their price forecasts for EROS have a consensus price objective of $4.50. The analysts have set the share’s price value over the next 12 months at a high of $4.50 and a low of $4.50 should the stock experience a downside. Incidentally, analysts’ outlook for the Eros International Plc stock is 2.00 for the next 12 months. The average price target is 30.89% above its last price level and an upside to the estimated low will see the stock gain 30.89% over that period. But an upside of 30.89% will see the stock hit the forecast high price target while mean target price for the stock is $4.50.
The top 3 mutual fund holders in Eros International Plc are IPF Investment Fund – Global Oppo, iShares Russell 2000 ETF, and St. James Place Unit Trust – Glob. IPF Investment Fund – Global Oppo owns 2.39 million shares of the company’s stock, all valued at over $6.79 million. iShares Russell 2000 ETF sold 68544.0 shares to see its total holdings shrink to 1.47 million shares valued at over $4.17 million and representing 0.94% of the shares outstanding. St. James Place Unit Trust – Glob now owns shares totaling to 0.80% of the shares outstanding.
Shares of Eros International Plc (NYSE: EROS) opened at $3.24, up $0.08 from a prior closing price of $3.16. However, the script later closed the day at $3.11, down -1.58%. The company’s stock has a 5-day price change of 14.76% and -9.06% over the past three months. EROS shares are trading -8.26% year to date (YTD), with the 12-month market performance up to 84.02% higher. It has a 12-month low price of $1.10 and touched a high of $4.91 over the same period. Currently, 3.54 million shares have been traded, compared to an average intraday trading volume of 3.93 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 14.04%, 1.18%, and 9.54% respectively.
Institutional ownership of Eros International Plc (NYSE: EROS) shares accounts for 22.50% of the company’s 155.58M shares outstanding. Mutual fund holders own 18.37%, while other institutional holders and individual stakeholders account for 8.45% and — respectively.
It has a market capitalization of $549.57M and a beta (3y monthly) value of 1.06. The earnings-per-share (ttm) stands at -$3.23. Price movements for the stock have been influenced by the stock’s volatility, which stands at 7.89% over the week and 7.41% over the month.
Analysts forecast that Eros International Plc (EROS) will achieve an EPS of -$0.06 for the current quarter, $0 for the next quarter and $0.21 for 2022. The lowest estimate earnings-per-share for the quarter is -$0.06 while analysts give the company a high EPS estimate of -$0.06. Comparatively, EPS for the current quarter was $0.04 a year ago. Earnings per share for the fiscal year are expected to increase by 35.00%, and 395.24% over the next financial year.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 1 brokerage firm advisors rate Eros International Plc (EROS) as a “Moderate Buy” at a consensus score of 2.00. Specifically, 1 Wall Street analysts polled rate the stock as a buy, while 0 of the 1 advise that investors “hold,” and 0 rated it as a “Sell.”
Looking at the support for the EROS, a number of firms have released research notes about the stock. Citigroup stated their Buy rating for the stock in a research note on August 14, 2018, with the firm’s price target at $16. Wells Fargo coverage for the Eros International Plc (EROS) stock in a research note released on December 09, 2016 offered a Outperform rating with a price target of. BofA/Merrill was of a view on November 24, 2015 that the stock is Neutral, while Jefferies gave the stock Buy rating on November 18, 2015, issuing a price target of $40- $21. Jefferies on their part issued Buy rating on August 12, 2015.